0000000000465373

AUTHOR

Frédéric J. Mercier

showing 1 related works from this author

The human near-term myometrialβ3-adrenoceptor but not theβ2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation

2004

1. In order to compare the beta(2)- and beta(3)-adrenoceptor (beta-AR) desensitisation process in human near-term myometrium, we examined the influence of a pretreatment of myometrial strips with either a beta(2)- or a beta(3)-AR agonist (salbutamol or SR 59119A, respectively, both at 10 microm, for 5 and 15 h) on the relaxation and the cyclic adenosine monophosphate (cAMP) production induced by these agonists. 2. To assess some of the mechanisms potentially implicated in the beta-AR desensitisation process, we studied the influence of such treatment on the number of beta(2)- and beta(3)-AR binding sites, the beta(2)- and beta(3)-AR transcripts expression and the phosphodiesterase 4 (PDE4) …

PharmacologyAgonist0303 health sciencesmedicine.medical_specialtyChemistrymedicine.drug_classMyometriumPhosphodiesteraseStimulationPharmacology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicineSalbutamolmedicineCyclic adenosine monophosphateReceptorBeta (finance)030217 neurology & neurosurgery030304 developmental biologymedicine.drugBritish Journal of Pharmacology
researchProduct